UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 9, 2022 4:00 P.M.

Form:	F-3
CIK: 0001612940 Company Name: ProQR Therapeutics N.V. File Number: 333-263166